These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32386192)

  • 1. Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting.
    Zhang Q; Xu K; Chen M; Miao Y; Wang N; Xu Z; Xu H
    Saudi J Gastroenterol; 2020; 26(3):160-167. PubMed ID: 32386192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of circulating tumor cells and analysis of clinicopathological factors in liver cancer.
    Cui K; Ou Y; Ning D; Li H; Xi Y; Li S
    J Cancer Res Ther; 2022 Apr; 18(2):452-460. PubMed ID: 35645114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
    Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
    Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.
    Jie XX; Zhang M; Du M; Cai QQ; Cong Q; Xu CJ; Zhang XY
    Transl Cancer Res; 2022 Aug; 11(8):2636-2646. PubMed ID: 36093536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
    Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
    Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
    Bueno de Oliveira T; Camila Braun A; Ribaldo Nicolau U; Ali Abdallah E; da Silva Alves V; Hugo Fonseca de Jesus V; Fernando Calsavara V; Paulo Kowaslki L; Domingos Chinen LT
    Oral Oncol; 2021 Oct; 121():105480. PubMed ID: 34403888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment.
    Hao YJ; Chang LW; Yang CY; Lo LC; Lin CP; Jian YW; Jiang JK; Tseng FG
    Transl Res; 2024 Jan; 263():1-14. PubMed ID: 37558203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of circulating tumor cells and microemboli to predict diagnosis and prognosis in diffuse glioma.
    Qi Y; Xu Y; Yan T; Xiong W; Zhu X; Sun Q; Deng G; Yuan F; Ye L; Hu P; Liu B; Zhang S; Deng S; He Y; Wu G; Ye Q; Chen Q
    J Neurosurg; 2024 Sep; 141(3):673-683. PubMed ID: 38608304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
    Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
    Li H; Song P; Zou B; Liu M; Cui K; Zhou P; Li S; Zhang B
    Medicine (Baltimore); 2015 Sep; 94(38):e1565. PubMed ID: 26402816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
    Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma.
    Chang MC; Chang YT; Chen JY; Jeng YM; Yang CY; Tien YW; Yang SH; Chen HL; Liang TY; Wang CF; Lee EY; Chang YC; Lee WH
    Clin Chem; 2016 Mar; 62(3):505-13. PubMed ID: 26861552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer.
    Chen Y; Yuan J; Li Y; Li X; Yang Y; Li J; Li Y; Shen L
    Hum Cell; 2021 Sep; 34(5):1446-1454. PubMed ID: 34152566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between circulating tumor cells and Epstein-Barr virus activation in patients with nasopharyngeal carcinoma.
    He C; Huang X; Su X; Tang T; Zhang X; Ma J; Guo X; Lv X
    Cancer Biol Ther; 2017 Nov; 18(11):888-894. PubMed ID: 28121221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of circulating tumor cell monitoring in targeted therapy for gastrointestinal stromal tumors].
    Fan JB; Zhi XF; Chen SS; Zhu JW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):789-795. PubMed ID: 34530560
    [No Abstract]   [Full Text] [Related]  

  • 20. A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer.
    Abdallah EA; Souza E Silva V; Braun AC; Gasparini VA; Kupper BEC; Tariki MS; Tarazona JGR; Takahashi RM; Aguiar Júnior S; Chinen LTD
    Transl Oncol; 2021 Jan; 14(1):100932. PubMed ID: 33157516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.